Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.65 EUR | +3.74% | +3.74% | -8.56% |
26/04 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
26/04 | STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research remains Neutral | ZD |
Sales 2024 * | 276M 295M 24.58B | Sales 2025 * | 297M 317M 26.45B | Capitalization | 506M 541M 45.15B |
---|---|---|---|---|---|
Net income 2024 * | 19M 20.32M 1.69B | Net income 2025 * | 25M 26.73M 2.23B | EV / Sales 2024 * | 2.33 x |
Net Debt 2024 * | 137M 147M 12.22B | Net Debt 2025 * | 75.66M 80.89M 6.75B | EV / Sales 2025 * | 1.96 x |
P/E ratio 2024 * |
25.4
x | P/E ratio 2025 * |
19.6
x | Employees | 1,480 |
Yield 2024 * |
2.31% | Yield 2025 * |
2.18% | Free-Float | 59.43% |
Latest transcript on Stratec SE
1 day | +3.74% | ||
1 week | +3.74% | ||
Current month | +3.61% | ||
1 month | -1.77% | ||
3 months | -1.77% | ||
6 months | +7.76% | ||
Current year | -8.56% |
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 01/98/01 |
Robert Siegle
DFI | Director of Finance/CFO | 56 | 01/98/01 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 57 | 29/19/29 |
Georg Heni
CHM | Chairman | 66 | 20/22/20 |
Rolf Vornhagen
BRD | Director/Board Member | 70 | 21/20/21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.86% | 125 M€ | -.--% | ||
0.34% | 17 M€ | -.--% | - | |
0.01% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 41.65 | +3.74% | 18,423 |
25/24/25 | 40.15 | -3.25% | 40,381 |
24/24/24 | 41.5 | +0.24% | 16,531 |
23/24/23 | 41.4 | +3.24% | 6,321 |
22/24/22 | 40.1 | -0.12% | 3,839 |
Delayed Quote Xetra, April 26, 2024 at 09:05 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.56% | 541M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- SBS Stock